Recent Activity
-
Choose your management approach and defend it.
-
Although the American College of Cardiology and the European Society of Cardiology now advise people with ICDs not to participate in vigorous sports, ...
-
The European Medicines Agency (EMA) said last week that it was initiating a review of the combined use of agents that block the renin-angiotensin syst...
-
A large observational study has found no difference in the increased risk for cardiovascular disease between the two main classes of drugs used in the...
-
This week’s topics include the safety and efficacy of sitagliptin for type 2 diabetes, use of glucocorticoids and the risk of VTE, and forced smoking abstinence.
-
In the crucial early stages of a possible myocardial infarction (MI), EMTs on the scene now rely on slow and unreliable proprietary technology to tran...
-
An Institute of Medicine report on salt earlier this week sparked a lot of controversy. The report concludes that there's no evidence to support curre...
-
This is why we hold conferences — to share in the value of research and to promote enthusiasm to continue with new endeavors.
-
The majority of patients who receive an ICD for primary prevention without a pacing indication have a dual-chamber ICD implanted. Although there are a...
-
This week’s topics include the ADVANCE III trial, the latest fish-oil supplement study, and a review of management strategies for asymptomatic carotid stenosis.
-
First results in human patients of a novel leadless pacemaker were presented last week at the HRS meeting in Denver by Vivek Reddy. Pacemaker leads a...
-
Looking back at the knowledge gained and friendships kindled at HRS 2013, this Fellow looks forward to HRS 2014.
-
I finally managed to walk to the Fellows in Training lounge, hoping to connect with some co-fellows. I did find lot of fellows, but to my surprise Dr. Zipes was there and ready to answer burning questions about getting published.
-
In recent weeks the cardiac resynchronization therapy (CRT) field has been absorbing the publication of the BLOCK HF trial in the New England Journal ...
-
HRS yields useful insights, both personal and professional.
-
Encouraging long-term results from the PROTECT AF trial comparing the Watchman left atrial appendage closure device to warfarin in atrial fibrillation...
-
An emotion-raising debate, a late-breaker session, and technological innovations focus this fellow, despite Denver’s many attractions.
-
Many patients receiving an ICD or a pacemaker are already receiving oral anticoagulants. Current guidelines recommend replacement of the oral anticoag...
-
Another large study has failed to find any benefits for fish oil supplements. The Italian Risk and Prevention Study, published in the New England Jour...
-
A fellow experiences one exceptional presentation after another at the first day of HRS 2013.
